ENTA logo

Enanta Pharmaceuticals (ENTA) Long Term Debt

Annual Long Term Debt

$53.94 M
+$32.70 M+153.99%

September 30, 2024


Summary


Performance

ENTA Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTAbalance sheetmetrics:

Quarterly Long Term Debt

$53.94 M
+$5.81 M+12.06%

September 30, 2024


Summary


Performance

ENTA Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTAbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

ENTA Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+154.0%+154.0%
3 y3 years+4690.7%+4690.7%
5 y5 years+10000.0%+4690.7%

ENTA Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+4690.7%at high+256.9%
5 y5-yearat high>+9999.0%at high+4690.7%
alltimeall timeat high-100.0%at high-100.0%

Enanta Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sep 2024
$53.94 M(+154.0%)
$53.94 M(+12.1%)
Jun 2024
-
$48.14 M(+10.9%)
Mar 2024
-
$43.41 M(+111.5%)
Dec 2023
-
$20.52 M(-3.4%)
Sep 2023
$21.24 M(-5.1%)
$21.24 M(-4.9%)
Jun 2023
-
$22.33 M(-3.2%)
Mar 2023
-
$23.07 M(+5.6%)
Dec 2022
-
$21.86 M(-2.3%)
Sep 2022
$22.37 M(+1886.9%)
$22.37 M(+0.7%)
Jun 2022
-
$22.21 M(+46.9%)
Mar 2022
-
$15.12 M(-5.3%)
Dec 2021
-
$15.96 M(+1317.2%)
Sep 2021
$1.13 M(-70.7%)
$1.13 M(-31.2%)
Jun 2021
-
$1.64 M(-38.1%)
Mar 2021
-
$2.64 M(-24.9%)
Dec 2020
-
$3.52 M(-8.3%)
Sep 2020
$3.84 M
$3.84 M(-15.6%)
Jun 2020
-
$4.55 M(-14.7%)
Mar 2020
-
$5.33 M(-11.0%)
DateAnnualQuarterly
Dec 2019
-
$5.99 M(+2893.5%)
Sep 2019
$200.00 K(-31.7%)
$200.00 K(-10.7%)
Jun 2019
-
$224.00 K(-10.0%)
Mar 2019
-
$249.00 K(-8.1%)
Dec 2018
-
$271.00 K(-7.5%)
Sep 2018
$293.00 K(-22.7%)
$293.00 K(-7.0%)
Jun 2018
-
$315.00 K(-6.5%)
Mar 2018
-
$337.00 K(-5.9%)
Dec 2017
-
$358.00 K(-5.5%)
Sep 2017
$379.00 K(-17.2%)
$379.00 K(-5.7%)
Jun 2017
-
$402.00 K(-4.5%)
Mar 2017
-
$421.00 K(-4.3%)
Dec 2016
-
$440.00 K(-3.9%)
Sep 2016
$458.00 K(-13.4%)
$458.00 K(-4.2%)
Jun 2016
-
$478.00 K(-6.8%)
Mar 2016
-
$513.00 K(0.0%)
Dec 2015
-
$513.00 K(-3.0%)
Sep 2015
$529.00 K(>+9900.0%)
$529.00 K(+202.3%)
Jun 2015
-
$175.00 K(>+9900.0%)
Sep 2014
$0.00
$0.00

FAQ

  • What is Enanta Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals annual long term debt year-on-year change?
  • What is Enanta Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly long term debt year-on-year change?

What is Enanta Pharmaceuticals annual long term debt?

The current annual long term debt of ENTA is $53.94 M

What is the all time high annual long term debt for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high annual long term debt is $53.94 M

What is Enanta Pharmaceuticals annual long term debt year-on-year change?

Over the past year, ENTA annual long term debt has changed by +$32.70 M (+153.99%)

What is Enanta Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of ENTA is $53.94 M

What is the all time high quarterly long term debt for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high quarterly long term debt is $53.94 M

What is Enanta Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, ENTA quarterly long term debt has changed by +$32.70 M (+153.99%)